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Abstract
Achievements in regenerative medicine have demonstrated that using differ-
ent kinds of stem cells can have some stimulating effect on the reparative re-
generation processes of the nervous system. To stimulate nerve regeneration, 
the experimental elaboration of mesenchymal stem cell (MSC) transplantation 
is carried out actively. There is evidence that MSCs promote growth of the re-
cipient regenerating axons after transplantation into the damaged nerve or the 
conduit. However, processes that happen in transplanted cells and these cells’ 
differentiation are poorly studied. The aim of the present study is to describe 
the localization and morphologically peculiar properties of bone marrow-de-
rived mesenchymal stem cells after their allotransplantation into the injured 
nerve of a rat. MSCs from Wistar—Kyoto rats were cultivated for seven days 
and labeled with BrdU three days before using. The sciatic nerves of adult Wi-
star—Kyoto rats were damaged, and suspensions of BrdU-labeled cultured 
MSCs were immediately transplanted into the damaged sciatic nerves. Five to 
seven days after transplantation, the surviving MSCs were found. Using fluores-
cent microscopy, we found that some of the transplanted cells were localized 
in the epineurium and in the perineurium. Some of the transplanted MSCs dif-
ferentiated into adipocytes and cells of the perineurium.
Keywords: MSCs, differentiating, nerve, epineurium, perineurium, adipocytes, 
immunohistochemistry, fluorescence microscopy.
Introduction
Modern regenerative medicine has demonstrated that transplantation of differ-
ent kinds of stem cells can have a stimulating effect on the processes of reparative 
regeneration of the central and peripheral nervous system (Southwell et al., 2014; 
Li, Hu, and Cheng, 2015; Sokolova and Polyntsev, 2017). In recent years, experi-
mental elaboration of different cellular technologies to stimulate regeneration of 
damaged nerves is being carried out intensively. There are many reviews on this 
issue (Walsh and Midha, 2009; Petrova, 2012; Fairbairn et al., 2015, Shchanitsyn et 
al., 2017; Petrova, 2018). There is evidence that mesenchymal stem cells (MSCs), 
derived from bone marrow, adipose tissue, umbilical cord stroma, amniotic fluid 
and other tissues, promote growth of the recipient regenerating axons after trans-
plantation into a damaged nerve or into a conduit (Dezawa et al., 2001; Kingham 
et al., 2007; Chen et al., 2007; Wong et al., 2011; Masgutov et al., 2018). The stimu-
lating effect of MSCs on repair processes in nervous tissue is explained by their 
properties. MSCs are able to produce neurotrophic and angiogenic substances. 
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It has been shown that they release brain-derived neu-
rotrophic factor (BDNF), glial cell-derived neurotrophic 
factor (GDNF), vascular endothelial growth factor-A 
(VEGF-A), and angiopoietin-1 proteins (Kingham et al., 
2007). It has also been found that injection of MSCs into 
damaged nerves leads to an increase in the number of 
blood vessels in the distal segment of the injured nerve 
trunk (Petrova, Isaeva, Kolos, and Korzhevskii, 2018). 
An important property of MSCs is their ability to modu-
late the immune response (Stagg and Galipeau, 2013). 
Clinical use of adipose-derived stem cells and umbilical 
cord mesenchymal stem cells was the result of experi-
mental studies (Li et al., 2013; Gallyamov et al., 2015). 
However, the fate of the transplanted cells and their dif-
ferentiation is poorly studied. Researchers mainly study 
the cells that are found after transplantation within the 
endoneurium of a nerve trunk. However, some of the 
transplanted cells are found in the nerve connective 
tissue shells of the recipient after their transplantation 
into the nerve. This fact has been noted only in indi-
vidual works (Zhang et al., 2004; Petrova, Isaeva, and 
Korzhevskii, 2016). 
The purpose of the present study was to describe 
the localization and morphological features of bone 
marrow-derived mesenchymal stem cells after their al-
lotransplantation in damaged nerves of rats.
Material and Methods 
CULTURE OF MSCS
MSCs derived from bone marrow of Wistar-Kyoto rats 
were provided by Trans-Technologies Ltd. (Saint Pe-
tersburg, Russia, General Director D. G. Polyntsev). The 
method of obtaining MSCs and their characteristics 
were described in more detail earlier by N. Zin´kova et 
al. (2007). Cells were cultured for a week, using a cul-
ture flask (NEST Scientific, USA) and culture medium 
MEM alpha (BioloT, Russia) supplemented with bovine 
serum. Three days prior to using the culture, 5-bromo-
2-deoxyuridine (BrdU) (Sigma, USA) was added to the 
medium. The MSC suspension was washed twice with 
the medium without BrdU and centrifuged for 15 min 
(200 g). The precipitate was resuspended in 1 ml of fresh 
medium, and viability of the cells was tested using 0.2% 
trypan blue solution (BioloT, Russia) and by cell calcu-
lation in a Goryaev chamber. The cell suspension was 
used for transplantation if the viability of the latter was 
at least 90%. 
NERVE DAMAGE AND MSC TRANSPLANTATION INTO  
THE NERVE
Adult male Wistar—Kyoto rats were used (n = 12); their 
housing and all experiments were carried out according 
to the rules for work with experimental animals. During 
all experiments, euthanasia was carried out in compli-
ance with the international regulations of the Declara-
tion of Helsinki on humane treatment of animals and 
“The rules for conducting studies with the use of experi-
mental animals” (Order no. 755  of 12.08.1977, Minis-
try of Public Health). The research was approved by the 
local Ethics Committee of the Institute of Experimental 
Medicine, St. Petersburg, Russia (Protocol №3/17 of No-
vember 30, 2017).
The method of transplantation of MSCs was per-
formed according to a modification of the previously 
described method (Petrova and Isaeva, 2014). The sci-
atic nerves of recipient rats were lesioned by application 
of a ligature for 40  s at the level of the upper third of 
the thigh. A cell suspension (5×104 in 5 μl medium) was 
infused under the perineurium of the nerve trunk by a 
thin glass cannula. The surgery was conducted under an 
MBS-2 microscope (LOMO, Russia) under aseptic con-
ditions. 
The animals were then kept in standard vivarium 
conditions and were killed after one and five to seven 
days by an overdose of ethyl ether vapor. The nerve seg-
ments containing the transplant were fixed in a zinc–eth-
anol–formaldehyde solution according to the method of 
Korzhevskii et al. (2014). The material was embedded in 
paraffin after dehydration in alcohols of increasing con-
centration. The sections (5 μm in thickness) were pre-
pared using rotary microtome (RM 2125RT Leica, Ger-
many) and were mounted on silane-treated glass slides 
(HistoBond, Germany). Histological slides were stained 
with toluidine blue, astra-blue and aniline blue.
IMMUNOHISTOCHEMISTRY 
Immunohistochemical reaction to vimentin was used 
to characterize cultured MSCs. For light microscopy, 
immunohistochemical labeling was performed us-
ing murine monoclonal antibodies to vimentin (clone 
V-9) (Dako, Denmark) diluted 1  :  100. This immuno-
histochemical reaction was carried out on the culture of 
MSCs, directly in the culture flasks. After that, reagents 
from the EnVision+System Labeled Polymer_HRP An-
tiMouse kit (K4001, Dako, Denmark) were used. 3’3-di-
aminobenzidine (DAB+ kit) (Dako, Denmark) was used 
as a chromogen to visualize the reaction product. Some 
of the samples were additionally stained with astra-blue 
dye. Histological slides were analyzed using a light mi-
croscope Leica DM750  (Germany), and photos were 
taken using the camera ICC50 (Leica, Germany). A LAS 
EZ software (Leica, Germany) was used for image pro-
cessing.
The transplanted mesenchymal stem cells of the 
graft were identified by immunohistochemical reaction 
to BrdU. After the standard procedure of deparaffiniza-
tion and rehydration, sections were exposed to heat-
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induced antigen retrieval (HIAR), followed by block-
ing endogenous peroxidase. Monoclonal antibodies to 
BrdU (Bu20a clone, Dako, Denmark, at a dilution 1: 
100) were used. For light microscopy, reagents from the 
EnVision+System Labeled Polymer_HRP AntiMouse 
kit (K4001, Dako, Denmark) and 3’3-diaminobenzidine 
(DAB+ kit) (Dako, Denmark) were used. For fluores-
cence microscopy, biotinylated anti-mouse antibodies 
and streptavidin, conjugated with fluorescent carbocya-
nine dye (Сy2, Jackson ImmunoResearch, USA) were 
applied. Immunohistochemical marking of the perineu-
rium on longitudinal sections through the nerve was 
also performed, using polyclonal antibodies to Clau-
din-1 (Dako, Denmark). The anti-rabbit secondary anti-
bodies, conjugated with TRITC (Dako, Denmark) were 
used. The sections were examined and photographed 
using a fluorescence microscope: Leica DM2500, Leica 
DFC420 digital camera (Leica, Germany) and a fluores-
cent Nikon N-SIM&N-STORM Super-Resolution Mi-
croscope (Nikon, Japan).
Results
This work examined bone marrow MSCs of the second 
passage. Adhesiveness is a characteristic property of 
MSCs in culture. This made it possible to study MSCs di-
rectly in culture flasks. The MSCs were fixed and stained 
just in the cell culture flasks. Astra-blue staining of the 
MSCs revealed their morphological features. MSCs are 
fibroblast-like cells with processes and a rounded or oval 
nucleus. Immunohistochemical reaction to vimentin — 
an intermediate filament protein — was applied. It was 
found that vimentin is present in the cytoplasm of cul-
tured MSCs (Fig. 1).
A suspension of the cultured MSCs was prepared 
for transplantation. Three days before the application of 
the cells, BrdU was added to the cultured medium. To 
make sure that the BrdU was absorbed into the MSCs, 
a smear of suspension cells was prepared, and BrdU im-
munohistochemistry was performed on these smears. 
Analysis of histological samples showed BrdU presence 
in most MSCs: the brown-colored nucleus indicates 
BrdU uptake into the cell (Fig. 2a). Therefore, BrdU-la-
beled MSCs can easily be distinguished from the recipi-
ent’s cells five to seven days after transplantation under 
the perineurium of the sciatic nerve. 
Five to seven days after surgery, the injured nerve 
fibers of recipients showed signs of Wallerian degenera-
tion. We observed an increase of the mononuclear cells 
number and the appearance of nerve fiber swelling, the 
dilatation of blood vessels, and the thickening of nerve 
sheaths. The fragmentation of the axons and the myelin 
debris could not be detected because of the applied fixa-
tion and histological processing of the material.
Fig. 1. MSCs in a culture flask. Immunohistochemical reaction to vimentin, astra-blue staining ×400 (a), ×1000 (b, c)
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Analysis of the sections showed that the number 
of transplanted MSCs in the nerve is quite small one 
(Fig. 2b, c) and five to seven (Fig. 2d) days after trans-
plantation. The cells labeled with BrdU were detected 
in the nerve trunk one day after transplantation. It was 
found that clusters of BrdU-containing cells were located 
between the recipient nerve fibers, endogenous Schwann 
cells, fibroblasts and blood vessels (Fig. 2c) of the nerve 
trunk. Only single BrdU-labeled cells were found in the 
endoneurium of the recipient nerve trunk. Transplanted 
MSCs labeled with BrdU were found mainly in the epi-
neurium and in the perineurium (Fig. 3). 
The epineurium is the outer connective-tissue 
sheath of the nerve. It consists of blood vessels, adipose 
tissue, connective tissue cells and collagen fibers. The 
transplanted cells were revealed in the walls of blood 
vessels and in the adipose tissue. Some of the adipocyte 
nuclei contained BrdU (Fig. 3b). These BrdU-containing 
large cells have a round or polygonal shape and contain 
fat vacuoles, with the nucleus displaced to the periphery 
and a thin border of cytoplasm. 
Some of the transplanted BrdU-labeled MSCs were 
found in the perineurium (Fig. 2d, 3a, 4). The perineu-
rium is a layering of specialized cells that lies close to 
the epineurium and surrounds and protects the nerve 
fibers of the endoneurium. Тhere are three zones of 
perineurium on the sections stained with toluidine blue 
(Fig.  2d). The inner zone is separated from the endo-
neurium by the subperineurial space and is formed by a 
layer of perineurial cells with several tight junctions. The 
intermediate zone consists of several layers of cells. The 
external zone is the transition area between the perineu-
rium and epineurium, where the laminated structure of 
perineurial cells is lost and several wide bundles of col-
lagen, similar to those found in the epineurium, can be 
observed. Tight junction proteins (ZO-1, occludin, and 
claudins) are present in perineurial cells. Claudine1  is 
one of the immunohistochemical markers of perineurial 
cells. Using fluorescence microscopy and antibodies to 
Claudine 1, we studied the inner layer of the perineu-
rium. In Fig. 4 the protein tight contacts of the perineu-
rial cells are colored red. It can be seen that transplanted 
Fig. 2. BrdU-containing MSCs in a smear (a), in the sciatic nerve 1 day after transplantation (b, c), in the perineurium 5 days after transplantation 
(d). Immunohistochemical reaction on BrdU (a-d), astra-blue staining (a), toluidine blue staining (b), anilin blue staining (d). ×400, ×100.
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Fig. 4. BrdU-labeled (arrows) transplanted cells in the recipient perineurium 7 days after transplantation in the rat sciatic nerve. Immunohis-
tochemical reaction to BrdU (а, d, g). Immunohistochemical reaction to claudin1 (b, e, h). Double positive staining for claudin1 (red) and BrdU 
(green) (c, f, i). N — endoneurium of the recipient’s nerve; P — perineurium; E — epyneurium. Fluorescence microscopy. ×600.
Fig. 3. BrdU-labeled MSCs in the connective tissue nerve sheaths (a) and adipocyte in adipose tissue of the recipient epineurium (b) 7 days after 
transplantation MSCs in the rat sciatic nerve. Immunohistochemical reaction on BrdU. Fluorescence microscopy. ×100, ×600.
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BrdU-containing MSCs are located near this layer. The 
nuclei of the transplanted cells are flattened (Fig. 5). This 
form is typical for perineurium cells. Thus, according to 
localization of MSCs and the shape of their nuclei, we 
can conclude that they have differentiated into perineu-
ral cells.
Discussion
Bone marrow mesenchymal stem cells (MSCs), which 
are widely used in regenerative medicine in recent 
years, were used in this work. MSCs were first detected 
in bone marrow stroma by Friedenstein and colleagues 
(Friedenstein, Piatetzky-Shapiro, and Petrakova, 1966; 
Friedenstein, Chailakhyan, and Gerasomov, 1987). 
MSCs are mesodermal cells that form connective tis-
sue throughout the body and give rise to fibroblasts, os-
teoblasts, chondrocytes, fat (Pitterger et al., 1999) and 
endothelial cells (Dennis and Charbord, 2002). Follow-
up studies have described the surface markers of MSCs 
(Pulin, Saburina, and Repin, 2008) and have defined the 
ability of these cells to secrete various biologically ac-
tive substances. It has been shown that MSCs are able to 
produce growth and trophic factors such as epidermal 
growth factor (EGF), hepatocyte growth factor (HGF), 
fibroblast growth factor (FGF), transforming growth 
factor β (TGFβ), BDNF, GDNF, NGF and extracellular 
matrix proteins (Chen et al., 2007; Brochlin et al., 2009). 
The rat bone marrow mesenchymal stem cells used in 
the present study were previously characterized by 
Zin´kova et al. (2007). Their phenotype (97% — CD90+) 
corresponds to the phenotype of bone marrow multi-
potent stromal cells. The cells we use have morphologi-
cal features inherent in MSCs: cells exhibit the adhesive 
property and contain the intermediate filaments pro-
tein — vimentin — in the cytoplasm (Fig. 1). In research 
conducted on different types of animals, it has been 
found that the introduction of bone marrow MSCs into 
the nerve or conduit connecting the ends of a damaged 
nerve promotes the regeneration of nerve fibers (review: 
Petrova, 2015). However, the mechanisms of this effect 
are poorly understood. The investigation of MSC differ-
entiation potential and of the processes occurring with 
MSCs after transplantation into the recipient tissues can 
explain the stimulation of regeneration. The need for 
research on the fate of transplanted mesenchymal stem 
cells also explains the fact that, in recent years, a large 
number of clinical research has been conducted in this 
direction (Xue et al., 2011; Li et al., 2013; Gallyamov et 
al., 2015; Bogov et al., 2016; Cohen et al., 2018). 
In the present study, we carried out subperineural 
allotransplantation of rat MSCs into injured nerves of 
the recipients. Five to seven days after surgery, we de-
tected most of BrdU-immunopositive cells not in the 
endoneurium, where they were placed, but in the outer 
nerve shells. We assume that MSCs migrate from the 
endoneurium into the nerve sheaths. MSCs are known 
to have a high migration potential. The number of cells 
surviving after the transplantation was small, since ap-
parently most of the transplanted cells died. The ques-
tion of how long exogenous MSCs can maintain their 
viability in recipient tissues is debatable. Some authors 
have detected pre-labeled MSCs even a few months after 
transplantation (Evaristo‑Mendonca et al., 2018). How-
ever, other authors note that MSCs survive about 10 days 
after transplantation into the brain, and by 20 days they 
have completely degenerated (Loseva et al., 2012). 
Fig. 5. Cell nucleus morphology of transplanted BrdU-labeled cells in 
the perineurium of the recipient 7 days after operation. Double posi-
tive staining for claudin1(red) and BrdU (green). ×2000.
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Regarding the differentiation potential of bone mar-
row MSCs, this issue needs to be discussed separately. 
There is evidence that MSCs are able to differentiate into 
various types of cells (cardiomyocytes, astrocytes, neu-
rons and others) under certain conditions in vitro (Mar-
tin et al., 2002; Wislet-Gendebien et al., 2005; Yang et al., 
2008) and in vivo (Kopen, Prockop, and Phinney, 1999). 
Several studies demonstrate the potential of MSCs to 
differentiate into Schwann cells (Chen et al., 2006; Frat-
tini et al., 2012). Schwann cells or neurolematocytes are 
glial elements of the peripheral nervous system that per-
form many important functions and provide a micro-
environment for the regenerating axons in the damaged 
nerve (Jessen, Mirsky, and Lloyd, 2015). Schwann cells 
represent the majority of the cellular elements of the 
nerve. They are located along the nerve fibers. The nu-
clei of the Schwann cells have a specific elongated shape 
and differ from the nuclei of endotheliocytes and fibro-
blasts, which make up less than 5% of the nerve trunk. It 
has been shown that MSCs can be stimulated towards 
differentiation into Schwann cells by their cocultivation 
with dorsal root ganglion neurons (Chen et al., 2006) 
or by the addition of glial growth factor-2 (GFG-2) 
into the culture medium. Directional differentiation of 
bone marrow mesenchymal stem cells using GFG was 
done before their transplantation into the nerve (Tohill, 
Mantovani, Wiberg, and Terenghi, 2004). These MSCs, 
labeled by retroviral gene transfer with green fluores-
cent protein, were transplanted into the damaged nerve. 
15 days after transplantation, they maintained the abil-
ity to express Schwann cell markers and improved nerve 
regeneration.
In this study, we have shown that some of the 
grafted MSCs are found in the epineural sheath and 
differentiate into adipose tissue cells five to seven days 
after transplantation into the nerve. One of the charac-
teristic of MSCs isolated from bone marrow (or other 
sources) is their in vitro differentiation in three direc-
tions: bone, cartilage and adipose tissue cells. Therefore, 
the detection of BrdU-labeled adipocytes indicates that 
the transplanted cells realize their potencies when they 
are in a characteristic microenvironment — in the loose 
connective tissue of the epineurium. The detection of 
MSCs that had differentiated into perineurium cells was 
unexpected. Many authors have investigated the struc-
ture and function of this nerve sheath (Chumasov, 1975; 
Zochodne, 2008). The perineurium is characterized by 
the presence of occluding junctions (zonula occludens 
or tight junctions) and gap junctions (zonula adherens), 
which are necessary for the implementation of the neu-
ro-tissue barrier. Perineurial cells have polygonal forms, 
a thin, flat cytoplasm and form several layers; the base-
ment membranes are placed between them. Extracellu-
lar matrix proteins such as laminin, fibronectin, collagen 
and glycosaminoglycans are present in the perineurium. 
Apparently, it is the presence of these proteins that cre-
ates a favorable biological environment for survival of 
MSCs and for their differentiation into perineurium 
cells. 
The origin of perineurium cells in ontogenesis has 
been a subject of discussion for a long time (Zochodne, 
2008). It was established that perineurium cells do not 
have a neural crest cell origin, but instead derive from 
mesenchymal cells, i.e. fibroblasts, which surround adja-
cent nerve fibers in formation (Bunge et al., 1989; Joseph 
et al., 2004). This study once again confirms the mesen-
chymal origin of perineurium cells. The effect of extra-
cellular matrix proteins on the differentiation of MSCs 
has been shown in studies performed in vitro (Gron-
thos, Simmons, Graves, and Robey, 2001)  and in vivo 
(Gonzalez-Perez et al., 2018).
Some modern scientific literature presents data on 
the stimulation of nerve regeneration with the use of 
MSCs obtained not from bone marrow, but from other 
sources (Fairbairn et al., 2015). From our point of view, 
the research of Japanese authors Tamaki et al. (2014) was 
performed flawlessly and is particularly interesting. In 
this work, MSCs were derived from the skeletal muscle 
of green fluorescent protein transgenic mice, and they 
were transplanted into severely crushed mouse nerves. 
It turned out that these cells, being in a new microenvi-
ronment, differentiated into both Schwann cells and the 
cells of the recipient nerve sheath. A comparative study 
showed that MSCs derived from skeletal muscle have 
a greater differentiation potential than MSCs of bone 
marrow. It is important to note that the search for new 
tissue sources of MSCs for transplantation into nerves 
is associated with the danger of negative consequences 
for the recipient. For example, MSCs derived from skel-
etal muscle can lead to the appearance of a tumor after 
transplantation into the nerve, which was shown in 2013 
(Lavasani et al., 2013).
In scientific literature there is no unified opinion on 
the mechanisms of MSC influence on nerve regenera-
tion. Using RT-PCR, it has been shown that MSCs pro-
duce NGFβ, BDNF, NGF and NT-3 (Peng et al., 2011). 
Due to their ability to synthesize trophic factors, they 
stimulate the proliferation of recipient Schwann cells 
(Ribeiro-Resende et al., 2012). On the other hand, the 
effect is related to the possible differentiation of MSCs 
into Schwann cells under the influence of trophic factors 
released from the proximal end of the cut nerve. How-
ever, this assumption does not always find experimental 
confirmation (Shen et al., 2010; Evaristo‑Mendonca et 
al., 2018). In this study, we were also unable to show the 
possibility of differentiating MSCs into Schwann cells.
There is evidence of vascularization improvement 
in the damaged nerve due to the use of cellular therapy 
(Tamaki et al., 2014; Petrova, Isaeva, Kolos, and Ko-
rzhevskii, 2018; Evaristo‑Mendonca et al., 2018). In our 
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previous work, we showed that the number of microves-
sels in the damaged rat nerve trunk increases one and a 
half times after the application of MSCs (Petrova, 2018; 
Evaristo‑Mendonca et al., 2018). Our current explana-
tion of this fact is that MSCs produce angiogenic fac-
tors. Some experiments on MSC transplantation into 
the ischemic heart or liver demonstrate that these cells 
can differentiate into endotheliocytes of blood vessels 
(Yoon et al., 2005; El’chaninov et al., 2017). The ques-
tion about the differentiation of MSCs into endothelial 
cells after their transplantation into a nerve or conduit 
is debatable. This differentiation has been noted only 
in individual works (Petrova, Isaeva, and Korzhevskii, 
2016; Evaristo-Mendonca et al., 2018). The data we ob-
tained earlier, using light microscopy, showed that cells 
transplanted into damaged nerves localize to the walls 
of the emerging blood vessels (Petrova, Isaeva, and Ko-
rzhevskii, 2016). This fact needs to be confirmed with 
double marking in our further studies. This year, direct 
evidence has suggested that MSCs, developing in the 
conduit that connects the proximal and distal nerve 
stumps, can differentiate into vascular smooth muscle 
cells (Evaristo-Mendonca et al., 2018).
In the present study we have shown that MSCs 
obtained from the bone marrow of Wistar–Kyoto rats 
survive for seven days after allotransplantation into the 
damaged sciatic nerve. Most of the transplanted cells are 
localized in the connective tissue sheaths of the recipient 
nerve. We found that a certain number of transplanted 
cells differentiate into adipocytes and perineurium cells. 
Our further studies will show if such transplantation has 
a stimulating effect on nerve regeneration. 
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